Search research articles
Contact Us
Filters
Showing results (21-30 of 277) with videos related to
Page
of 28
Sort By:
International Journal of Cancer
|
August 19, 2005
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin
Kimio Yonesaka, Kenji Tamura, Takayasu Kurata, et al.
International Journal of Clinical Oncology
|
June 15, 2007
Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience
Toshio Shimizu, Taroh Satoh, Kenji Tamura, et al.
BMC Cancer
|
July 15, 2022
Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy
Toshifumi Yamaguchi, Hisato Kawakami, Daisuke Sakai, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 22, 2013
[Esophageal cancer]
Taroh Satoh, Toshihiro Kudo, Daisuke Sakai, et al.
Anticancer Research
|
February 29, 2024
Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer
Shinsuke Hara, Daisuke Sakai, Kenji Ikemura, et al.
Japanese Journal of Clinical Oncology
|
November 19, 2010
Does 1 year adjuvant chemotherapy with oral 5-FUs in colon cancer reduce the peak of recurrence in 1 year and provide long-term OS benefit?
Chikuma Hamada, Junichi Sakamoto, Taroh Satoh, et al.
Future Oncology (London, England)
|
October 21, 2025
ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancer
Hiroki Yukami, Toshifumi Yamaguchi, Shunji Endo, et al.
International Journal of Oncology
|
March 6, 2017
The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review)
Masamitsu Konno, Ayumu Asai, Koichi Kawamoto, et al.
International Journal of Cancer
|
November 23, 2007
Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk
Takeshi Yoshida, Isamu Okamoto, Takafumi Okabe, et al.
Frontiers in Oncology
|
November 7, 2022
Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment
Hiromichi Sato, Kazuki Sasaki, Tomoaki Hara, et al.
Page
of 28
Search research articles
Search
Showing results (21-30 of 277) with videos related to
Sort By:
Page
of 28
International Journal of Cancer
|
August 19, 2005
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin
Kimio Yonesaka, Kenji Tamura, Takayasu Kurata, et al.
International Journal of Clinical Oncology
|
June 15, 2007
Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience
Toshio Shimizu, Taroh Satoh, Kenji Tamura, et al.
BMC Cancer
|
July 15, 2022
Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy
Toshifumi Yamaguchi, Hisato Kawakami, Daisuke Sakai, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 22, 2013
[Esophageal cancer]
Taroh Satoh, Toshihiro Kudo, Daisuke Sakai, et al.
Anticancer Research
|
February 29, 2024
Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer
Shinsuke Hara, Daisuke Sakai, Kenji Ikemura, et al.
Japanese Journal of Clinical Oncology
|
November 19, 2010
Does 1 year adjuvant chemotherapy with oral 5-FUs in colon cancer reduce the peak of recurrence in 1 year and provide long-term OS benefit?
Chikuma Hamada, Junichi Sakamoto, Taroh Satoh, et al.
Future Oncology (London, England)
|
October 21, 2025
ASTRON (OGSG 2401) study protocol: Ferric carboxymaltose for iron deficiency anemia in gastrointestinal cancer
Hiroki Yukami, Toshifumi Yamaguchi, Shunji Endo, et al.
International Journal of Oncology
|
March 6, 2017
The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review)
Masamitsu Konno, Ayumu Asai, Koichi Kawamoto, et al.
International Journal of Cancer
|
November 23, 2007
Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk
Takeshi Yoshida, Isamu Okamoto, Takafumi Okabe, et al.
Frontiers in Oncology
|
November 7, 2022
Targeting the regulation of aberrant protein production pathway in gastrointestinal cancer treatment
Hiromichi Sato, Kazuki Sasaki, Tomoaki Hara, et al.
Page
of 28